-
Prestige: Cough-cold category down 15%
TARRYTOWN, N.Y. — Cough-cold suppliers are presently operating in a challenging environment, noted Matthew Mannelly, Prestige Brands CEO, president and director, during a conference call Thursday. The return of Tylenol to the cough-cold aisle and the accompanying media splash from McNeil Consumer isn't the only competitive factor impacting the cough-cold category, Mannelly said. The season is down more than 15% versus last year. And that lack of consumption, coupled with an overall soft retail environment, is forcing retailers to significantly cut back on inventories.
-
West Virginia considering making PSE prescription-only
CHARLESTON, W.Va. — West Virginia took one step closer to making pseudoephedrine products prescription-only, as the state's Senate Committee on Health voted Tuesday to move ahead with the proposal, according to an Associated Press report.
According to the report, the bill would allow an exception for certain over-the-counter drugs that are deemed "tamper resistant" by the Board of Pharmacy.